An observational study in Diabetic Macular Edema, sponsored by Superior University. Active, not recruiting at 1 site in Pakistan. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2024-06-10.
Sponsored by Superior University · Observational
It will investigate a novel treatment approach for diabetic macular edema (DME), which causes vision impairment in diabetic patients. It will focuse on the efficacy and safety of administering triamcinolone acetonide via suprachoroidal injection, targeting the space between the sclera and choroid.
This method aims to enhance drug delivery to the retina, potentially improving outcomes compared to conventional treatments. Participants receive suprachoroidal injections, and the study measures changes in macular thickness and visual acuity. The study's findings could offer a promising alternative to existing DME treatments, aiming to provide better management of the condition and improved patient quality of life.
841 studies on the registry are indexed under Macular Edema; 56 are open to participants now.
This study's enrollment of 36 is below the median of 97 across 163 observational studies indexed under Macular Edema.
Browse Macular Edema studies →Superior University is the lead sponsor of 242 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Diabetic Macular Edema patient having Diabetes for more than 2 years
Exclusion Criteria:
observing the eye behavior in Diabetic Macular Edema
Visual Acuity Testing
Visual acuity testing evaluates the participants' ability to discern letters or symbols at a standardized distance, providing a measure of vision clarity. This tool helps determine the functional improvement in vision.
Time frame: 12 Months
Optical Coherence Tomography
OCT is employed to assess changes in macular thickness, providing detailed cross-sectional images of the retina. This non-invasive imaging technique helps quantify the extent of macular edema and monitoring
Time frame: 12 months
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Superior University